← All candidates
One insider buy in the last year — $257.7K in all.
Thomas H. Kean, Jr.Foreign Affairs · Energy and Commercetraded 27 Aug · filed 12 Sep · selfSell (part)$1K–$15Kself27 Aug12 Sep
Richard McCormickScience, Space, and Technology · Armed Services +1traded 30 Jul · filed 14 Aug · selfSell$1K–$15Kself30 Jul14 AugThomas H. Kean, Jr.Foreign Affairs · Energy and Commercetraded 29 Jun · filed 15 Jul · selfSell (part)$1K–$15Kself29 Jun15 Jul143 filings on record.
JNJJOHNSON & JOHNSON
NYSE · Healthcare · $635.65B
$266.32
+0.28% · Sep 14
One insider buy in the last year — $257.7K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy● 25 sells◆ 2 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 3 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$635.65B
Float
2406.0M
100% public
Short % float
Pro
Price / profit
30.6
Price / future profit
21.5
Price / sales
6.5
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Morikis John G
Bought $257.7K on Nov 26 — 1,250 sh @ $206.15, held direct, 68% of their stake.
1 of 1 position beat the S&P
Congress
▸ Disclosures lag trades by 30–45 days.
23 disclosures12 mo
MemberTypeAmountOwnerTradedFiled
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
138 more transactions on Pro →Context
Wall St
$252.87 avg target
-5.1% vs today · 23 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26$2.70 act+$0.02
Q4 '25$2.46 act−$0.00
Q3 '25$2.80 act+$0.04
Q2 '25$2.77 act+$0.09
Coverage
Johnson & Johnson CEO Says Cure for Certain Cancers Is Realistic GoalThe Wall Street Journal · 06-16How to Build $3,000 a Month in Dividend Income to Cover the Average Social Security Check24/7 Wall St. · 06-16J&J drops key cancer trial results as Wall Street eyes stockTheStreet · 06-16Can BMY's Camzyos Strengthen Its Cardiovascular Portfolio?Zacks · 06-16
The file stays open
143 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice
